Mara Bonelli

3.1k citations
63 papers · 2.5k · 1 hit paper · h-index 31

Impact in

  • Oncology top 5%
    • HER2/EGFR in Cancer Research
    • Lung Cancer Research Studies
    • Cancer-related Molecular Pathways
    • Lung Cancer Treatments and Mutations
    • Advanced Breast Cancer Therapies

Papers in

Mara Bonelli

62 papers receiving 2.5k citations

Mara Bonelli's Hit Papers

Targeting PI3K/AKT/mTOR pathway in non small cell lung cancer 2014 · 390 citations
3900+4+8Years since publication100200300

Peers

Mara Bonelli
Comparison fields: 5 of 110
  • Oncology 952
  • Pulmonary and Respiratory Medicine 926
  • Aging 48
  • Cancer Research 397
  • Molecular Biology 1.3k
Replace Zhao-Lei Zeng with:
Zhao-Lei Zeng China
Yvonne Ottaviano United States
Sabina Cosulich United Kingdom
Zhuchu Chen China
Ker Yu United States
Stephano S. Mello Brazil
Robertus A.M. de Bruin United Kingdom
Zachary T. Schafer United States
Nelofer Syed United Kingdom
Mara Bonelli relative to Zhao-Lei Zeng China Zhao-Lei Zeng's profile →
Citations per field
00.5×1.5×
Zhao-Lei Zeng · 1×
Citations per year

Countries citing papers authored by Mara Bonelli

Since Specialization
Citations

This map shows the geographic impact of Mara Bonelli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mara Bonelli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mara Bonelli more than expected).

Fields of papers citing papers by Mara Bonelli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mara Bonelli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mara Bonelli. The network helps show where Mara Bonelli may publish in the future.

Co-authors

The 25 scholars most cited alongside Mara Bonelli, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mara Bonelli Line = papers co-authored together Mara Bonelli links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 63 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Targeting PI3K/AKT/mTOR pathway in non small cell lung cancer
Hit paper breakdown →
2014390
2 2002113
3 201884
4 201782
5 200282
6 201281
7 201976
8 200868
9 201767
10 200967
11 201363
12 201962
13 201660
14 200657
15 201455
16 200355
17 201554
18 201954
19 200148
20 201346

About Mara Bonelli

Mara Bonelli is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology, Oncology, Cell Biology and Physiology, having authored 63 papers that have together received 2.5k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (21 papers), PI3K/AKT/mTOR signaling in cancer (14 papers), HER2/EGFR in Cancer Research (9 papers), Advanced Breast Cancer Therapies (9 papers), Occupational and environmental lung diseases (9 papers), Cancer-related Molecular Pathways (7 papers), Heat shock proteins research (7 papers) and Genetics, Aging, and Longevity in Model Organisms (5 papers). The work is most often cited by research in Oncology (952 citations), Pulmonary and Respiratory Medicine (926 citations), Aging (48 citations), Cancer Research (397 citations) and Molecular Biology (1.3k citations). Mara Bonelli has collaborated with scholars based in Italy, United Kingdom and Netherlands. Frequent co-authors include Roberta Alfieri, Pier Giorgio Petronini, Claudia Fumarola, Andrea Cavazzoni, Silvia La Monica, Maricla Galetti, Daniele Cretella, Angelo F. Borghetti, Marcello Tiseo and Graziana Digiacomo. Their work appears in journals such as Biochemical Pharmacology, Cancers, Frontiers in Oncology, The Journal of Physiology and Current Pharmaceutical Design.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact